Ambu ready for price war on market for single-use devices

Ambu faces increased competition as a new major player might be entering single-use endoscope market next year. CEO Juan Jose Gonzalez has an answer ready for the increasing competition, which is that of lowering the price of single-use endoscopes.

Ambu CEO Juan Jose Gonzalez. | Photo: Ambu/PR

The CEO of the Danish firm Ambu is keenly aware of the firm's competitors and the growing single-use endoscopy market, especially, will be attacked from many sides in the following year.

Ambu is especially fighting US competitors such as Boston scientific and Verathon for market shares, but the Ambu CEO Juan Jose Gonzalez' eyes are set on Japanese Olympus, which he thinks about to enter the market.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs